Sign In
Buy TRMK
Trustmark Earnings Calls
| Release date | Oct 28, 2025 |
| EPS estimate | $0.95 |
| EPS actual | $0.94 |
| EPS Surprise | -1.05% |
| Revenue estimate | 209.2M |
| Revenue actual | 243.158M |
| Revenue Surprise | 16.23% |
| Release date | Jul 22, 2025 |
| EPS estimate | $0.86 |
| EPS actual | $0.92 |
| EPS Surprise | 6.98% |
| Revenue estimate | 206.125M |
| Revenue actual | 249.08M |
| Revenue Surprise | 20.84% |
| Release date | Apr 22, 2025 |
| EPS estimate | $0.82 |
| EPS actual | $0.88 |
| EPS Surprise | 7.32% |
| Revenue estimate | 195.35M |
| Revenue actual | 167.724M |
| Revenue Surprise | -14.14% |
| Release date | Jan 28, 2025 |
| EPS estimate | $0.83 |
| EPS actual | $0.92 |
| EPS Surprise | 10.84% |
| Revenue estimate | 195.033M |
| Revenue actual | 169.177M |
| Revenue Surprise | -13.26% |
Last 4 Quarters for Trustmark
Below you can see how TRMK performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jan 28, 2025 |
| Price on release | $36.52 |
| EPS estimate | $0.83 |
| EPS actual | $0.92 |
| EPS surprise | 10.84% |
| Date | Price |
|---|---|
| Jan 22, 2025 | $35.16 |
| Jan 23, 2025 | $35.02 |
| Jan 24, 2025 | $35.69 |
| Jan 27, 2025 | $36.23 |
| Jan 28, 2025 | $36.52 |
| Jan 29, 2025 | $37.38 |
| Jan 30, 2025 | $37.40 |
| Jan 31, 2025 | $37.50 |
| Feb 03, 2025 | $36.91 |
| 4 days before | 3.87% |
| 4 days after | 1.07% |
| On release day | 2.35% |
| Change in period | 4.98% |
| Release date | Apr 22, 2025 |
| Price on release | $33.80 |
| EPS estimate | $0.82 |
| EPS actual | $0.88 |
| EPS surprise | 7.32% |
| Date | Price |
|---|---|
| Apr 15, 2025 | $32.36 |
| Apr 16, 2025 | $32.47 |
| Apr 17, 2025 | $32.75 |
| Apr 21, 2025 | $32.69 |
| Apr 22, 2025 | $33.80 |
| Apr 23, 2025 | $33.88 |
| Apr 24, 2025 | $33.47 |
| Apr 25, 2025 | $33.34 |
| Apr 28, 2025 | $33.68 |
| 4 days before | 4.45% |
| 4 days after | -0.355% |
| On release day | 0.237% |
| Change in period | 4.08% |
| Release date | Jul 22, 2025 |
| Price on release | $38.72 |
| EPS estimate | $0.86 |
| EPS actual | $0.92 |
| EPS surprise | 6.98% |
| Date | Price |
|---|---|
| Jul 16, 2025 | $38.00 |
| Jul 17, 2025 | $38.30 |
| Jul 18, 2025 | $38.55 |
| Jul 21, 2025 | $38.52 |
| Jul 22, 2025 | $38.72 |
| Jul 23, 2025 | $38.34 |
| Jul 24, 2025 | $38.59 |
| Jul 25, 2025 | $38.67 |
| Jul 28, 2025 | $38.25 |
| 4 days before | 1.89% |
| 4 days after | -1.21% |
| On release day | -0.98% |
| Change in period | 0.658% |
| Release date | Oct 28, 2025 |
| Price on release | $38.70 |
| EPS estimate | $0.95 |
| EPS actual | $0.94 |
| EPS surprise | -1.05% |
| Date | Price |
|---|---|
| Oct 22, 2025 | $37.97 |
| Oct 23, 2025 | $38.04 |
| Oct 24, 2025 | $38.74 |
| Oct 27, 2025 | $38.73 |
| Oct 28, 2025 | $38.70 |
| Oct 29, 2025 | $37.95 |
| Oct 30, 2025 | $37.24 |
| Oct 31, 2025 | $37.22 |
| Nov 03, 2025 | $37.39 |
| 4 days before | 1.92% |
| 4 days after | -3.39% |
| On release day | -1.94% |
| Change in period | -1.53% |
Trustmark Earnings Call Transcript Summary of Q3 2025
Trustmark reported continued momentum in Q3 with diversified loan growth (loans held for investment +0.6% linked quarter, +3.4% YoY) and strong deposit inflows (+3.4% linked quarter, noninterest-bearing deposits +5.9% linked quarter). Net income was $56.8 million, EPS $0.94 (+2.2% linked quarter, +11.9% YoY), ROA 1.21% and ROTCE 12.84%. Net interest income rose 2.4% to $165.2 million and NIM was 3.83%. Credit quality remained solid (net charge-offs 13 bps annualized; ACL 1.2% of loans). Noninterest expense increased, partly from hiring (about 29 new hires in Q3, 21 production-related) and $2.3 million of nonroutine items. Capital strengthened (CET1 11.88%, total risk-based 14.33%); $11 million of buybacks in the quarter ($37 million YTD) with $63 million remaining authorization. Board declared $0.24 quarterly dividend. Management affirmed full-year guidance for loan and deposit growth, noninterest income/expense, and tightened NIM guidance to 3.78%–3.82%. They remain focused on organic growth in targeted markets (Houston, Atlanta, Birmingham, Huntsville, parts of Florida and Alabama), will be opportunistic on M&A, and expect continued disciplined capital deployment (preference for organic loan growth, market expansion, M&A, and opportunistic buybacks).
